Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Elevations“
Suchtreffer
Begriffe & Kennungen
Alecensa · 4.8 · Adverse reactions of bilirubin elevations were reported in 25.9 % of the patients treated with Alecensa across
Eintrag öffnenAlecensa · 4.8 · Concurrent elevations in ALT or AST greater than or equal to three times the ULN and total bilirubin greater t
Eintrag öffnenAlecensa · 4.8 · Severe myalgia and CPK elevations Cases of myalgia (35.3 %) including myalgia events (24.2 %), arthralgia (16.
Eintrag öffnenAlunbrig · 4.8 · Elevations of ALT and AST were reported in 49% and 68% of patients treated with Alunbrig, respectively at the
Eintrag öffnenAlunbrig · 4.8 · Elevations of amylase and lipase were reported in 47% and 54% of patients treated with Alunbrig, respectively
Eintrag öffnenAlunbrig · 4.8 · Elevations of pancreatic enzymes
Eintrag öffnenAlunbrig · 4.8 · In ALTA 1L and ALTA, elevations of CPK were reported in 64% of patients treated with Alunbrig at the 180 mg re
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Hepatic enzyme elevations (2%), hepatic injury and autoimmune hepatitis (including exacerbation of underlying
Eintrag öffnenAmgevita · 4.8 · 76 No ALT elevations ≥ 3 × ULN occurred in the phase 3 trial of adalimumab in paediatric patients with plaque
Eintrag öffnenAmgevita · 4.8 · No ALT elevations ≥ 3 X ULN occurred in the phase 3 trial of adalimumab in paediatric patients with plaque pso
Eintrag öffnenAmsparity · 4.8 · No ALT elevations ≥ 3 x ULN occurred in the Phase 3 trial of adalimumab in paediatric patients with plaque pso
Eintrag öffnenAmsparity · 4.8 · No ALT elevations ≥ 3 x ULN occurred in the Phase 3 trial of adalimumab in paediatric patients with plaque pso
Eintrag öffnenAmsparity · 4.8 · No ALT elevations ≥3 x ULN occurred in the Phase 3 trial of adalimumab in paediatric patients with plaque psor
Eintrag öffnenAptivus · 4.8 · 25 co-infection with hepatitis B or C were risk factors for these elevations. Most patients were able to conti
Eintrag öffnenAptivus · 4.8 · Hyperlipidaemia Grade 3 or 4 elevations of triglycerides occurred more frequently in the tipranavir with riton
Eintrag öffnenBaraclude · 4.8 · 28 In clinical studies with lamivudine-refractory patients, 4% had ALT elevations > 3 times baseline, and < 1%
Eintrag öffnenBaraclude · 4.8 · Exacerbations during treatment: in studies with nucleoside naive patients, on treatment ALT elevations > 10 ti
Eintrag öffnenBaraclude · 4.8 · Exacerbations during treatment: in studies with nucleoside naive patients, on treatment ALT elevations > 10 ti
Eintrag öffnenBaraclude · 4.8 · In clinical studies with lamivudine-refractory patients, 4% had ALT elevations > 3 times baseline, and < 1% ha
Eintrag öffnenBaraclude · 4.8 · Laboratory test abnormalities: In clinical studies with nucleoside-naive patients, 5% had ALT elevations > 3 t
Eintrag öffnen